#WorldHealthDay: 422 million adults in developing countries live with diabetes

Picture by: Peter Byrne/PA Wire/Press Association Images.
Picture by: Peter Byrne/PA Wire/Press Association Images.

World Health Organisation (WHO) is calling for global action to halt rise in and improve care for people with diabetes after new figures show the number of people living with diabetes has almost quadrupled since 1980 to 422 million adults, with most living in developing countries.

Factors driving this dramatic rise include overweight and obesity, WHO announced ahead of World Health Day which is today (April 7).

WHO is marking its annual World Health Day (7 April), which celebrates the Organisation’s founding in 1948, by issuing a call for action on diabetes.

“If we are to make any headway in halting the rise in diabetes, we need to rethink our daily lives: to eat healthily, be physically active, and avoid excessive weight gain,” says Dr Margaret Chan, WHO Director-General.

“Even in the poorest settings, governments must ensure that people are able to make these healthy choices and that health systems are able to diagnose and treat people with diabetes.”

Among the key findings from the WHO’s Global Report on Diabetes are:

  • The number of people living with diabetes and its prevalence are growing in all regions of the world. In 2014, 422 million adults (or 8.5 per cent of the population) had diabetes, compared with 108 million (4.7 per cent) in 1980.
  • The epidemic of diabetes has major health and socioeconomic impacts, especially in developing countries.
  • In 2014, more than 1 in 3 adults aged over 18 years were overweight and more than one in 10 were obese.
  • The complications of diabetes can lead to heart attack, stroke, blindness, kidney failure and lower limb amputation. For example, rates of lower limb amputation are 10 to 20 times higher for people with diabetes.
  • Diabetes caused 1.5 million deaths in 2012. Higher-than-optimal blood glucose caused an additional 2.2 million deaths by increasing the risks of cardiovascular and other diseases. Many of these deaths (43 per cent) occur prematurely, before the age of 70 years, and are largely preventable through adoption of policies to create supportive environments for healthy lifestyles and better detection and treatment of the disease.
  • Good management includes use of a small set of generic medicines; interventions to promote healthy lifestyles; patient education to facilitate self-care; and regular screening for early detection and treatment of complications.
  • Global commitments to reduce diabetes

“Many cases of diabetes can be prevented, and measures exist to detect and manage the condition, improving the odds that people with diabetes live long and healthy lives,” says Dr Oleg Chestnov, WHO’s Assistant Director-General for NCDs and Mental Health.

“But change greatly depends on governments doing more, including by implementing global commitments to address diabetes and other NCDs.”

WHO suggest that these also include meeting Sustainable Development Goal (SDG) target 3.4, which calls for reducing premature death from NCDs, including diabetes, by 30 per cent by 2030.

Governments have also committed to achieving 4 time-bound national commitments set out in the 2014 UN General Assembly Outcome Document on Noncommunicable Diseases, and attaining the nine global targets laid out in the WHO Global Action Plan for the Prevention and Control of NCDs, which include halting the rise in diabetes and obesity, WHO reports.

“Around 100 years after the insulin hormone was discovered, the “Global report on diabetes” shows that essential diabetes medicines and technologies, including insulin, needed for treatment are generally available in only 1 in 3 of the world’s poorest countries,” says Dr Etienne Krug, Director of WHO’s Department for the Management of NCDs, Disability, Violence and Injury Prevention.

“Access to insulin is a matter of life or death for many people with diabetes. Improving access to insulin and NCD medicines in general should be a priority.”

Diabetes is a chronic, progressive noncommunicable disease (NCD) characterised by elevated levels of blood glucose (blood sugar). It occurs either when the pancreas does not produce enough of the insulin hormone, which regulates blood sugar, or when the body cannot effectively use the insulin it produces.

There are three main forms of diabetes: type 1, type 2 and gestational diabetes. The cause of type 1 diabetes is unknown and people living with it require daily insulin administration for survival.

Type 2 accounts for the vast majority of people living with diabetes globally, and is largely the result of excess body weight and physical inactivity. Once seen only in adults, type 2 diabetes is now increasingly occurring in children and young people.

Gestational diabetes is a temporary condition that occurs in pregnancy and carries long-term risk of type 2 diabetes. Gestational diabetes is present when blood glucose values are above normal but still below those diagnostic of diabetes.

Global efforts are underway to make medicines, including for NCDs, more available and affordable.

Commitments from world leaders, including the SDGs, the 2011 UN Political Declaration on the Prevention and Control of Noncommunicable Diseases, the 2014 UN General Assembly Outcome Document on Noncommunicable Diseases, and the work of the UN Secretary-General’s high-level panel on access to essential medicines are aimed at improving affordability and availability of essential drugs for people living with diabetes.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.